News

Significant breakthrough in NMN technology, anti-aging is no longer the patent of the wealthy

Significant breakthrough in NMN technology, reversing aging is no longer the patent of the wealthy



In recent years, NMN, known for its ability to reverse aging, has entered the public eye. NMN is currently the only substance that has been rigorously scientifically proven to have anti-aging effects on mammals and has been well received by the public. Previously, due to the difficulty of obtaining NMN, it could only be popular as a high-end luxury item in the wealthy circle, and some even said that NMN was exclusive to the wealthy. With the breakthrough progress in bioconversion enzyme technology, the emergence of Ruiweituo NAD+precursor NMN supplements to combat aging is a patent of the wealthy saying "no".



In 2016, emerging companies in Japan first introduced NAD+precursor NMN into the consumer market, but the cost of taking it remains unattainable for most people, and the road to mass production has not been smooth. Until the end of 2018, the Riverton NAD+precursor NMN supplement, launched by Herbalmax in collaboration with scientists from world-class academic and research institutions such as the California Institute of Technology and the University of Pennsylvania, sparked a wave of anti-aging worldwide. Riverton's core component is based on a NAD+precursor substance called nicotinamide mononucleotide (NMN), which only exists in trace amounts in animals and plants, And the imperfect extraction technology and extremely limited acquisition channels are also the reasons for its high price. The R&D team of Herbalmax has innovated in technology, taking the lead in utilizing enzyme catalyzed synthesis technology to significantly reduce the cost of NMN by more than 90%. They have also launched the world's first mature and practical NMN product, Ruiweituo. The research on NMN in the academic community is still advancing. In May of this year, the Shin-ichiro lmai research group at the University of Washington conducted a public experiment, stating that the mid-term results of long-term human trials of the key ingredient NAD+precursor NMN supplement of Ravitol were positive, and confirmed the oral safety of Ravitol at a similar dose to NAD+precursor NMN product, The paper published in Cell Metabolism once again confirms that injection significantly increases the levels of NAD+precursor NMN in mice, and significantly improves energy metabolism, muscle, eye and other organ functions. The experimental results show no significant side effects.



The key issue that has been difficult to overcome in the academic field of medicine has always been "aging and lifespan intervention". In December 2013, Harvard University in the United States publicly announced that NMN, a precursor substance of the key coenzyme NAD+responsible for DNA repair and cellular energy metabolism in living organisms, has a significant effect on reversing mammalian aging and prolonging lifespan. Scientists from top scientific research institutions such as Harvard University and Keio University in Japan have successively confirmed that the NAD+precursor NMN can significantly reverse the atrophy and degeneration caused by aging in mammals. With age, the NAD+content in the human body gradually decreases, and mitochondrial activity decreases, leading to accelerated aging of mitochondria, cells, and even the entire body, At this point, it is necessary to supplement NAD+precursor NMN to delay the aging process of the body. In fact, in NAD+precursor NM